Skip to main content
Log in

Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network

  • Research Letter
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Sampson CJ, Arnold R, Bryan S, Clarke P, Ekins S, Hatswell A, et al. Transparency in decision modelling: what, why, who and how? Pharmacoeconomics. 2019;37(11):1355–69. https://doi.org/10.1007/s40273-019-00819-z.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, et al. Achieving appropriate model transparency: challenges and potential solutions for making value-based decisions in THE United States. Pharmacoeconomics. 2019;37(11):1321–7. https://doi.org/10.1007/s40273-019-00832-2.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Harvard S, Werker GR, Silva DS. Social, ethical, and other value judgments in health economics modelling. Soc Sci Med. 2020;253: 112975. https://doi.org/10.1016/j.socscimed.2020.112975.

    Article  PubMed  Google Scholar 

  4. Elliott KC. A taxonomy of transparency in science. In: McCullagh M, editor. Canadian Journal of philosophy. Cambridge: Cambridge University Press; 2020. pp. 1–14. https://doi.org/10.1017/can.2020.21.

  5. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR-SMDM Modeling Good Research Practices Task Force. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force—7. Value Health. 2012;15(6):843–50. https://doi.org/10.1016/j.jval.2012.04.012.

  6. Feenstra T, Corro-Ramos I, Hamerlijnck D, van Voorn G, Ghabri S. Four aspects affecting health economic decision models and their validation. Pharmacoeconomics. 2022;40(3):241–8. https://doi.org/10.1007/s40273-021-01110-w.

    Article  PubMed  Google Scholar 

  7. Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, Tew M, et al. The challenge of transparency and validation in health economic decision modelling: a view from mount hood. Pharmacoeconomics. 2019;37(11):1305–12. https://doi.org/10.1007/s40273-019-00825-1.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Pouwels XGLV, Sampson CJ, Arnold RJG, Open Source Models Special Interest Group. Opportunities and barriers to the development and use of open source health economic models: a survey. Value Health. 2022;25(4):473–9. https://doi.org/10.1016/j.jval.2021.10.001.

  9. Sampson CJ, Wrightson T. Model registration: a call to action. Pharmacoecon Open. 2017;1(2):73–7. https://doi.org/10.1007/s41669-017-0019-2.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Adibi A, Harvard S, Sadatsafavi M. Programmable interface for statistical & simulation models (PRISM): towards greater accessibility of clinical and healthcare decision models. https://arxiv.org/abs/2202.08358

  11. Jansen JP, Incerti D, Linthicum MT. Developing open-source models for the US health system: practical experiences and challenges to date with the open-source value project. Pharmacoeconomics. 2019;37(11):1313–20. https://doi.org/10.1007/s40273-019-00827-z.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Harvard S, Werker GR. Health economists on involving patients in modeling: potential benefits, harms, and variables of interest. Pharmacoeconomics. 2021;39(7):823–33. https://doi.org/10.1007/s40273-021-01018-5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Staniszewska S, Hill EM, Grant R, Grove P, Porter J, Shiri T, et al. Developing a framework for public involvement in mathematical and economic modelling: bringing new dynamism to vaccination policy recommendations. Patient. 2021;14(4):435–45. https://doi.org/10.1007/s40271-020-00476-x.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Xie RZ, Malik ED, Linthicum MT, Bright JL. Putting stakeholder engagement at the center of health economic modeling for health technology assessment in the United States. Pharmacoeconomics. 2021;39(6):631–8. https://doi.org/10.1007/s40273-021-01036-3.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Harvard S, Winsberg E, Symons J, Adibi A. Value judgments in a COVID-19 vaccination model: a case study in the need for public involvement in health-oriented modelling. Soc Sci Med. 2021;286: 114323. https://doi.org/10.1016/j.socscimed.2021.114323.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II Good Practices Task Force. Value Health. 2022;25(1):10–31. https://doi.org/10.1016/j.jval.2021.10.008.

    Article  PubMed  Google Scholar 

  17. Emerson J, Bacon R, Kent A, Neumann PJ, Cohen JT. Publication of decision model source code: attitudes of health economics authors [published erratum appears in Pharmacoeconomics. 2019 Nov;37(11):1411]. Pharmacoeconomics. 2019;37(11):1409–10. https://doi.org/10.1007/s40273-019-00796-3.

  18. Global Health CEA Registry. About the clearinghouse. http://ghcearegistry.org/ghcearegistry/ Accessed 18 Apr 2022.

  19. Professional Society for Health Economics and Outcomes Research (ISPOR). Open Source Models Special Interest Group. 2022. https://www.ispor.org/member-groups/special-interest-groups/open-source-models. Accessed 18 Apr 2022.

Download references

Acknowledgements

The authors gratefully acknowledge Dr. Abdollah Safari for his assistance with data analysis, as well as anonymous participants in the evaluation survey and the numerous collaborators who have contributed to the production of educational videos hosted on the Peer Models Network YouTube page. The authors acknowledge financial support for this project from the British Columbia (BC) SUPPORT Unit Health Economics and Simulation Modelling (HESM) Methods Cluster (Award Number: HESM-302) and operating grants from the BC Academic Health Sciences Network. Stephanie Harvard gratefully acknowledges post-doctoral funding from Michael Smith Health Research BC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephanie Harvard.

Ethics declarations

Funding

Financial support for this project was received from the British Columbia (BC) SUPPORT Unit Health Economics and Simulation Modelling (HESM) Methods Cluster (Award Number: HESM-302) and the BC Academic Health Sciences Network. Stephanie Harvard receives post-doctoral funding from Michael Smith Health Research BC.

Conflict of interest

Stephanie Harvard, Amin Adibi, Adam Easterbrook, Gregory R. Werker, David Murphy, Don Grant, Alison Mclean, Zhina Majdzadeh, and Mohsen Sadatsafavi have no conflicts of interest or competing interests to declare related to this work.

Ethics Approval

Ethical approval was received (BC Provincial Research Ethics Platform H19-03918-A004).

Consent to participate

Survey participants provided consent to participate.

Consent for publication

The authors give their consent for publication.

Availability of data and material (data transparency)

Data are not available.

Code availability (software application or custom code)

Not applicable.

Authors' contributions

Stephanie Harvard: conceptualization, methodology, data curation, formal analysis, writing—original draft. Amin Adibi: conceptualization, methodology, data curation, formal analysis, writing—review and editing. Adam Easterbrook: methodology, formal analysis, writing—review and editing. Gregory R. Werker: conceptualization, writing—review and editing. David Murphy: conceptualization, writing—review and editing. Don Grant: conceptualization, writing—review and editing. Alison Mclean: conceptualization, writing—review and editing. Zhina Majdzadeh: writing—review and editing. Mohsen Sadatsafavi: conceptualization, methodology, writing—review and editing.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 28 KB)

Supplementary file2 (DOCX 21 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harvard, S., Adibi, A., Easterbrook, A. et al. Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network. PharmacoEconomics 40, 1005–1009 (2022). https://doi.org/10.1007/s40273-022-01179-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-022-01179-x

Navigation